Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$9.02 - $12.93 $588,843 - $844,096
-65,282 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$10.56 - $13.94 $224,928 - $296,922
-21,300 Reduced 24.6%
65,282 $792,000
Q4 2020

Feb 16, 2021

SELL
$9.44 - $13.3 $132,452 - $186,612
-14,031 Reduced 13.95%
86,582 $933,000
Q3 2020

Nov 16, 2020

BUY
$9.3 - $25.16 $935,700 - $2.53 Million
100,613 New
100,613 $952,000

Others Institutions Holding CNTG

About Centogene N.V.


  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $10.3M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.